Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Health-Related Quality of… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: a 20-Year Follow-up.

Artikel i vetenskaplig tidskrift
Författare Emily Krantz
Kerstin Landin-Wilhelmsen
Penelope Trimpou
Inger Bryman
Ulla Wide
Publicerad i The Journal of clinical endocrinology and metabolism
Volym 104
Nummer/häfte 11
Sidor 5073–5083
ISSN 1945-7197
Publiceringsår 2019
Publicerad vid Institutionen för odontologi, sektion 1
Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition
Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
Sidor 5073–5083
Språk en
Länkar dx.doi.org/10.1210/jc.2019-00340
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämneskategorier Endokrinologi, Obstetrik och gynekologi

Sammanfattning

The factors that affect the Health-Related Quality of Life (HRQoL) of women with Turner Syndrome (TS) are controversial.The aim was to describe the HRQoL of women with TS with a focus on how given growth hormone (GH) treatment and comorbidity influence HRQoL in adulthood, and to compare HRQoL of women with TS with that of women in the general population.Longitudinal cohort study, up to 20 years.The Turner Center at the Section for Endocrinology and Department of Reproductive Medicine at Sahlgrenska University Hospital, Gothenburg, Sweden.Women with TS, n=200, age range 16-78 yrs, were included consecutively and monitored every fifth year between 1995 and 2018. Women from the WHO-MONICA project were used as reference populations.HRQoL was measured using the Psychological General Well-Being index (PGWB) and the Nottingham Health Profile (NHP). Associations with somatic variables were assessed using longitudinal linear regression models.HRQoL was not associated with GH treatment in TS in spite of a mean 5.7 cm taller height. HRQoL was only associated with height per se in one of 13 subscales (p<0.01). HRQoL was negatively affected by higher age, higher age at diagnosis, and hearing impairment in TS. Women with TS reported a similar HRQoL to the reference population.No association between previous GH treatment and HRQoL was found during the up to 20-yrs of follow-up in women with TS. HRQoL of women with TS and the reference population was similar.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?